These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6131657)

  • 1. Alprazolam kinetics in the elderly. Relation to antipyrine disposition.
    Greenblatt DJ; Divoll M; Abernethy DR; Moschitto LJ; Smith RB; Shader RI
    Arch Gen Psychiatry; 1983 Mar; 40(3):287-90. PubMed ID: 6131657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.
    Ciraulo DA; Barnhill JG; Boxenbaum HG; Greenblatt DJ; Smith RB
    J Clin Pharmacol; 1986 Apr; 26(4):292-8. PubMed ID: 2871050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Moschitto LJ; Smith RB; Shader RI
    Br J Clin Pharmacol; 1983 Mar; 15(3):303-9. PubMed ID: 6133545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of propoxyphene with diazepam, alprazolam and lorazepam.
    Abernethy DR; Greenblatt DJ; Morse DS; Shader RI
    Br J Clin Pharmacol; 1985 Jan; 19(1):51-7. PubMed ID: 2858217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
    Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB
    Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of obesity on the pharmacokinetics of oral alprazolam and triazolam.
    Abernethy DR; Greenblatt DJ; Divoll M; Smith RB; Shader RI
    Clin Pharmacokinet; 1984; 9(2):177-83. PubMed ID: 6143633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men.
    Smith RB; Gwilt PR; Wright CE
    Clin Pharm; 1983; 2(2):139-43. PubMed ID: 6883942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of alprazolam.
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):45-7. PubMed ID: 6135693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, sex, and nitrazepam kinetics: relation to antipyrine disposition.
    Greenblatt DJ; Abernethy DR; Locniskar A; Ochs HR; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1985 Dec; 38(6):697-703. PubMed ID: 4064471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.
    Pourbaix S; Desager JP; Hulhoven R; Smith RB; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):447-51. PubMed ID: 2864320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alprazolam: pharmacokinetics, clinical efficacy, and mechanism of action.
    Fawcett JA; Kravitz HM
    Pharmacotherapy; 1982; 2(5):243-54. PubMed ID: 6133268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alprazolam (Xanax, the Upjohn Company).
    Evans RL
    Drug Intell Clin Pharm; 1981 Sep; 15(9):633-8. PubMed ID: 6115742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration.
    Smith RB; Kroboth PD; Vanderlugt JT; Phillips JP; Juhl RP
    Psychopharmacology (Berl); 1984; 84(4):452-6. PubMed ID: 6152055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alprazolam pharmacokinetics in alcoholic liver disease.
    Juhl RP; Van Thiel DH; Dittert LW; Smith RB
    J Clin Pharmacol; 1984; 24(2-3):113-9. PubMed ID: 6143766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alprazolam-related digoxin toxicity.
    Tollefson G; Lesar T; Grothe D; Garvey M
    Am J Psychiatry; 1984 Dec; 141(12):1612-3. PubMed ID: 6150651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibuprofen does not impair antipyrine clearance.
    Abernethy DR; Greenblatt DJ
    J Clin Pharmacol; 1983; 23(11-12):517-22. PubMed ID: 6662976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clobazam kinetics in the elderly.
    Greenblatt DJ; Divoll M; Puri SK; Ho I; Zinny MA; Shader RI
    Br J Clin Pharmacol; 1981 Nov; 12(5):631-6. PubMed ID: 6120710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and gender effects on chlordiazepoxide kinetics: relation to antipyrine disposition.
    Greenblatt DJ; Divoll MK; Abernethy DR; Ochs HR; Harmatz JS; Shader RI
    Pharmacology; 1989; 38(5):327-34. PubMed ID: 2762375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Harmatz JS; Shader RI
    J Pharmacol Exp Ther; 1982 Jan; 220(1):120-6. PubMed ID: 7053408
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects.
    Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Harmatz JS; Shader RI
    J Clin Pharmacol; 1998 Jan; 38(1):14-21. PubMed ID: 9597554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.